共 177 条
[1]
Holman RR(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes Lancet 352 837-853
[2]
Turner RC(2008)Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560-2572
[3]
Pan CY(2008)Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545-2559
[4]
Sinnassamy P(1995)Insulin therapy in type II diabetes Diabetes Res Clin Pract 28 Suppl S179-84
[5]
Chung KD(2015)Standards of medical care in diabetes - 2015 Diabetes Care 38 S1-89
[6]
Kim KW(2007)Insulin glargine versus NPH insulin therapy in Asian type 2 diabetes patients Diabetes Res Clin Pract. 76 111-118
[7]
Quan J(2016)Diabetes incidence and prevalence in Hong Kong, China during 2006–2014 Diabet Med 34 902-908
[8]
Li TK(2007)Cost-effectiveness and cost-utility of insulin glargine compared with NPH insulin based on a 10-year simulation of long-term complications with the diabetes mellitus model in patients with type 2 diabetes in Switzerland Int J Clin Pharmacol Ther 45 203-220
[9]
Pang H(2007)Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada Pharmacoeconomics 25 253-266
[10]
Choi CH(2004)The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making Curr Med Res Opin 20 S5-S26